Unlikely to cause harm — often a labeling or packaging issue.
Failed impurities/degradation specifications: (OOS) for Organic Impurities by HPLC (Impurity-A) during testing at the 18 months long term stability. Result: 1.1 percent. Spec: 1.0 percent.
| Brand name | FLUPHENAZINE HYDROCHLORIDE |
| Generic name | FLUPHENAZINE HYDROCHLORIDE |
| Active ingredient(s) | FLUPHENAZINE HYDROCHLORIDE |
| Distributed by / for | Ajanta Pharma USA Inc |
| NDC | 27241-255-01 |
| Full product label | Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-255-01. |
| Recalling firm | Ajanta Pharma USA Inc |
| Distribution | Nationwide within the U.S |
| Quantity | 403,200 tablets |
| Recall initiated | 2026-08-25 |
| Report date | 2026-09-16 |
| Recall completed | — |
| Recall number | D-0836-2026 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Bridgewater NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗